Design of mesoporous bioactive glass/hydroxyapatite composites for controllable co-delivery of chemotherapeutic drugs and proteins

Min Zhu,Jianhua Zhang,Cuilian Tao,Xing He,Yufang Zhu
DOI: https://doi.org/10.1016/j.matlet.2013.10.058
IF: 3
2014-01-01
Materials Letters
Abstract:Mesoporous bioactive glass/hydroxyapatite (MBG/HA) composites with controllable drug/protein delivery have been successfully developed by the mineralization of MBG materials in simulated body fluid (SBF). Using dexamethasone (DEX) and bovine serum albumin (BSA) as the model chemotherapeutic drug and protein, both DEX and BSA could be loaded in the MBG/HA composites with high loading capacities. Most importantly, the MBG/HA composites exhibited a simultaneously sustained DEX/BSA release behavior, and the DEX/BSA release rates were controlled by changing the mineralization period. It indicated that the mineralization of MBG materials to form the MBG/HA composites offered a simple and effective approach to realize the controllable co-delivery of chemotherapeutic drugs and proteins for bone regeneration.
What problem does this paper attempt to address?